| Description | Purity >98% by NMR, TLC. P5091 is a selective inhibitor of the ubiquitin-specific protease USP7 ( IC50=4.2 uM). Induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. P5091 displays antiangiogenic activity in vivo. Cell permeable. |